Evidence map›Paper›PMID 32023728›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2019

[Prognostic value of donor chimerism at +90 days after allogeneic hematopoietic stem cell transplantation in young patients with intermediate-risk acute myeloid leukemia].

Y Fei, X X Hu, Q Chen, A J Huang, H Cheng, X Ni, H Y Qiu, L Gao, G S Tang, J Chen and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Y FeiDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
X X HuDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Q ChenDepartment of Health Statistics, Second Military Medical University, Shanghai 200433, China.
A J HuangDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
H ChengDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
X NiDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
H Y QiuDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
L GaoDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
G S TangDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
J ChenDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
W P ZhangDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
J M YangDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
J M WangDepartment of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Changhai Hospital · CNSecond Military Medical University · CN

Funding

Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines in Shanghai 2017BR012National Natural Science Foundation of China 81530047, 81870143
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteAdolescentAdultChimerismFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesTransplantation, HomologousYoung AdultAllogeneic hematopoietic stem cell transplantationChimerismLeukemia, myeloid, acutePolymorphismSingle nucleotide

Identifiers

PMID32023728
PMCPMC7342688
OpenAlexW3013962721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.